You are here: Industry Insights > Moderna

News List

Moderna expects its COVID-19 vaccine to protect against UK coronavirus variant expresspharma
December 25, 2020
Moderna said it expects that the immunity induced by its COVID-19 vaccine would be protective against the coronavirus variants reported in the UK.
EC orders additional 80 million doses of Moderna’s COVID-19 vaccine europeanpharmaceuticalreview
December 22, 2020
Europe will receive an extra 80 million doses of Moderna’s mRNA-1273, a COVID-19 vaccine candidate, following the EC’s decision.
US CDC committee recommends Moderna’s Covid-19 vaccine for use in adults pharmaceutical-technology
December 22, 2020
The US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend the use of Moderna’s Covid-19 vaccine in adults under the Emergency Use Authorisation (EUA) issued by the US Food and Drug ...
FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine worldpharmanews
December 21, 2020
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
European Commission to purchase additional 80 mn doses of Moderna’s COVID-19 vaccine expresspharma
December 21, 2020
Moderna announced that the European Commission has exercised its option to purchase an additional 80 million doses of mRNA-1273, Moderna’s COVID-19 vaccine candidate, bringing its confirmed order commitment to 160 million doses.
US FDA Advisory Committee supports EUA for Moderna’s COVID-19 vaccine expresspharma
December 18, 2020
Moderna confirmed that the US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the FDA grant an emergency use authorisation (EUA) for the company’s COVID-19 vaccine candidate ...
US FDA report finds Moderna’s Covid-19 vaccine to have no specific safety concerns pharmaceutical-technology
December 16, 2020
The US Food and Drug Administration (FDA) in its briefing document stated that Moderna’s experimental Covid-19 vaccine, mRNA-1273, is 94.1% effective in preventing symptomatic Covid-19.
Moderna signs supply agreement with Singapore for COVID-19 vaccine expresspharma
December 15, 2020
Moderna recently announced data showing that mRNA-1273 remains stable at 2° to 8°C (36° to 46°F), the temperature of a standard home or medical refrigerator, for 30 days.
US orders additional 100 mn doses of Moderna’s COVID-19 vaccine expresspharma
December 14, 2020
Total of 200 million doses ordered by the US government to date, it retains option to purchase up to an additional 300 million doses.
India prepares for 600 mn COVID vaccine shots; to use standard cold storage: VK Paul expresspharma
December 14, 2020
India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems, said Dr VK Paul, the expert leading the initiative.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page